The Asthma Society of Ireland is aware of current shortages affecting certain brands of salbutamol nebules, the liquid form of salbutamol used in nebuliser devices. This does not affect standard blue reliever inhalers.
Alternative nebule products are available and can be reimbursed under existing community drug schemes.
If you are having difficulty accessing your prescribed nebules, please speak to your pharmacist.
While these shortages last, temporary arrangements are in place:
- If you have a Medical Card, your pharmacist can apply for reimbursement under the Discretionary Hardship Arrangements.
- If you are registered for the Drugs Payment Scheme (DPS), alternative products are supported under that.
- If you are not currently registered for a Medical Card or the DPS and think you may be eligible, your pharmacist or GP can advise you on how to apply.
As participation in certain reimbursement arrangements may vary between community pharmacies and local health regions, patients are encouraged to speak with their pharmacist, who can advise on the most appropriate options available locally.
Nebulised salbutamol remains an important treatment in severe or life-threatening asthma attacks. However, it is important to remember that, when used correctly, ten puffs of a blue reliever inhaler delivered one puff at a time through a spacer can provide a similar effect to a standard nebuliser dose.
Nebulisers should only be used at home under medical guidance, as inappropriate use may mask worsening symptoms and delay access to emergency care.
The Asthma Society encourages all people with asthma and their caregivers to be confident in using a spacer device correctly. Done properly, this technique is highly effective and can save lives.
Please find a video demonstrating this technique here.